jac_tb personal page - To The Moon

jac_tb

jac_tb

No personal profile

3Follow

5Followers

0Topic

0Badge

2021-08-21

Will it sell on news....

Sorry, the original content has been removed

2021-09-11

$Clover Health Corp(CLOV)$regret not taking profit when it rose to 11+

2021-08-21

Time will tell.... but by then, the answer may have come too late.

Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?

2021-06-07

$Bsquare Corp(BSQR)$first time buying this stock? What is its play like? Any potential target?

2021-05-21

$Microvision(MVIS)$stuck at $18+. What price can it reach?

2021-05-26

$Microvision(MVIS)$ Any news/reason for the price finally moving?

2021-04-20

$Microvision(MVIS)$high short volume. can we see MVIS do a GME?

2021-04-09

$Tiger Brokers(TIGR)$The tiger roars!

2021-03-27

Waiting for Roblox to do a GME!

Sorry, the original content has been removed

2021-03-24

The market is like a story. This has happened for more than a day but news came out later. Feels like a bigger hand is pacing the release of news so that there's some drama/story for the market each day.

Oil rises as Suez Canal ship runs aground, demand fears weigh

2021-03-12

[OK]

US Daylight Saving Time

2021-08-30

.

This Unloved Tech Stock Could Make You Rich One Day

2021-04-17

$Churchill Capital Corp IV(CCIV)$anybody knows what are the potential catalysts for this stock to rebound?

2021-03-07

$AVARGA LIMITED(U09.SI)$Waiting for PL to show his magic power. Be patient.

2021-06-29

.

Sorry, the original content has been removed

2021-06-25

.

Sorry, the original content has been removed

2021-06-01

$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?

2021-05-09

$Microvision(MVIS)$when can I see it green in my portfolio again...

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3565449260630555,"uuid":"3565449260630555","gmtCreate":1602355275444,"gmtModify":1615046426768,"name":"jac_tb","pinyin":"jactbjactb","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":3,"tweetSize":60,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":4,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.91%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":881542725,"gmtCreate":1631370487667,"gmtModify":1676530536939,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>regret not taking profit when it rose to 11+","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>regret not taking profit when it rose to 11+","text":"$Clover Health Corp(CLOV)$regret not taking profit when it rose to 11+","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/881542725","isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3554171307804467","authorId":"3554171307804467","name":"不轻易买股票","avatar":"https://static.tigerbbs.com/9591045ed55f6fad3186a4cd347989e0","crmLevel":1,"crmLevelSwitch":0},"content":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks.","text":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks.","html":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881542214,"gmtCreate":1631370455638,"gmtModify":1676530536930,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>.","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>.","text":"$Clover Health Corp(CLOV)$.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881542214","isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881542123,"gmtCreate":1631370418862,"gmtModify":1676530536926,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881542123","repostId":"1174332657","repostType":2,"repost":{"id":"1174332657","pubTimestamp":1631168952,"share":"https://www.laohu8.com/m/news/1174332657?lang=&edition=full","pubTime":"2021-09-09 14:29","market":"us","language":"en","title":"Why AMC, Clover, and Other Meme Stocks Tumbled On Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1174332657","media":"Motley Fool","summary":"The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value. And, at some point, people will want to take profits.","content":"<p>The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value. And, at some point, people will want to take profits.</p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>AMC Entertainment Holdings</b>(NYSE:AMC),<b>Skillz</b>(NYSE:SKLZ), and&nbsp;<b>Tonix Pharmaceuticals</b>(NASDAQ:TNXP)&nbsp;fell 0.9%, 8.3%, and 4.2% as of closed on Wednesday, with the fickle meme stock trading crowd reversing recent bullishness. Leading the charge for today's rout, however, is&nbsp;<b>Clover Health Investments</b>(NASDAQ:CLOV), down 12.5%.</p>\n<p><b>So what</b></p>\n<p>If you're looking for the headlines behind the moves, don't bother. There aren't any.</p>\n<p>As has been the case for the past few months, traders looking for a speculative edge are simply gathering around these stocks in an effort to collectively create the price action they desire, often by creating memes regarding these companies. Such efforts cause incredible price volatility.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3ba4680fa5e89ea08b364002d70d086f\" tg-width=\"2000\" tg-height=\"1201\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p>Many of these names -- like Clover this week -- have also been recently targeted as short-squeeze candidates. That's not a terribly bad bet right now either, to be fair, in that more than 7% of the outstanding shares of the&nbsp;health insurance&nbsp;company are currently tied up in short trades. That's enough short positions to prospectively spark en masse buying that drives the price sharply higher,<i>if</i>those short-sellers start becoming unnerved by a bit of bullishness. Tuesday's 15% jump for Clover shares didn't do the trick, however, with most of that gain being given back today.</p>\n<p>Shares of movie theater chain AMC Entertainment aren't really helping the broader bullish effort either. While one would expect this king of all meme stocks to soar following reports of&nbsp;record-breaking&nbsp;Labor Day weekend box office ticket sales, a bit of Tuesday's near-9% gain from AMC shares is also unwinding with Wednesday's1% sell-off. While that's hardly a devastating setback, the failure to follow through on Tuesday's advance is telling in and of itself.</p>\n<p>Of course, the broad market's sell-off today is also creating a headwind for these well-known meme stocks.</p>\n<p><b>Now what</b></p>\n<p>The advent of&nbsp;meme stock&nbsp;mania (and in particular, organized efforts to spark short squeezes) comes as no real surprise. If you give enough people enough time and the means of doing so, it's reasonable to expect them to capitalize on an opportunity -- including one they must plan out on one of the internet's more popular message boards. A little success on this front early this year prompted the trading crowd to replicate the effort.</p>\n<p>Regardless of the strategy's previous effectiveness, however, meme stock mania is losing steam. Not only are hedge funds and other managed investment pools now shoring up their risk exposure to short squeezes, traders are also running out of stocks they can push around.</p>\n<p>They're also running out of other buyers and bullish arguments.</p>\n<p>See, for most meme stocks to continue their rallies, new buyers must bring new money to the table to purchase shares from traders that have already scooped up the stock and are now looking to lock in a sizable profit. Enough people were willing to take such a swing early in the year when AMC was trading around $2 per share. Now that it's trading at more than $46 per share, however, would-be buyers are considerably less interested. Underscoring this idea is the fact that shares of Tonix Pharmaceuticals and Clover Health have yet to respond to the same rally driving strategies that -- at least for a while -- buoyed AMC stock. In a similar vein, Skillz shares have also stopped responding to the bullish prompts that drove the stock from around $11 per share in November of last year to February's high in excess of $46. They're now back near $11, unable to keep a rally going.</p>\n<p>There's something of a litmus test for the entire meme stock movement due this afternoon. Another meme stock company,<b>GameStop</b>(NYSE:GME), is slated to report its fiscal second-quarter numbers after today's closing bell rings. The numbers are important. But even more important is whether or not the trading crowd relaying on the web's popular message boards will be able to convince others to start and sustain a rally from GameStop. If it can, other meme stocks like AMC and Clover will remain at least somewhat in play. If it can't, it may well be a sign that the underlying strategy of individual traders targeting one ticker at a time is no longer effective. This in turn may sour most of them from even trying to do so, continuing the conversion of many of these meme names back to more conventionally priced stocks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why AMC, Clover, and Other Meme Stocks Tumbled On Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AMC, Clover, and Other Meme Stocks Tumbled On Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 14:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/08/why-amc-clover-and-other-meme-stocks-are-tumbling/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value. And, at ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/08/why-amc-clover-and-other-meme-stocks-are-tumbling/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SKLZ":"Skillz Inc","CLOV":"Clover Health Corp","AMC":"AMC院线","TNXP":"Tonix Pharmaceuticals Holding Co"},"source_url":"https://www.fool.com/investing/2021/09/08/why-amc-clover-and-other-meme-stocks-are-tumbling/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174332657","content_text":"The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value. And, at some point, people will want to take profits.\nWhat happened\nShares of AMC Entertainment Holdings(NYSE:AMC),Skillz(NYSE:SKLZ), and Tonix Pharmaceuticals(NASDAQ:TNXP) fell 0.9%, 8.3%, and 4.2% as of closed on Wednesday, with the fickle meme stock trading crowd reversing recent bullishness. Leading the charge for today's rout, however, is Clover Health Investments(NASDAQ:CLOV), down 12.5%.\nSo what\nIf you're looking for the headlines behind the moves, don't bother. There aren't any.\nAs has been the case for the past few months, traders looking for a speculative edge are simply gathering around these stocks in an effort to collectively create the price action they desire, often by creating memes regarding these companies. Such efforts cause incredible price volatility.\nIMAGE SOURCE: GETTY IMAGES.\nMany of these names -- like Clover this week -- have also been recently targeted as short-squeeze candidates. That's not a terribly bad bet right now either, to be fair, in that more than 7% of the outstanding shares of the health insurance company are currently tied up in short trades. That's enough short positions to prospectively spark en masse buying that drives the price sharply higher,ifthose short-sellers start becoming unnerved by a bit of bullishness. Tuesday's 15% jump for Clover shares didn't do the trick, however, with most of that gain being given back today.\nShares of movie theater chain AMC Entertainment aren't really helping the broader bullish effort either. While one would expect this king of all meme stocks to soar following reports of record-breaking Labor Day weekend box office ticket sales, a bit of Tuesday's near-9% gain from AMC shares is also unwinding with Wednesday's1% sell-off. While that's hardly a devastating setback, the failure to follow through on Tuesday's advance is telling in and of itself.\nOf course, the broad market's sell-off today is also creating a headwind for these well-known meme stocks.\nNow what\nThe advent of meme stock mania (and in particular, organized efforts to spark short squeezes) comes as no real surprise. If you give enough people enough time and the means of doing so, it's reasonable to expect them to capitalize on an opportunity -- including one they must plan out on one of the internet's more popular message boards. A little success on this front early this year prompted the trading crowd to replicate the effort.\nRegardless of the strategy's previous effectiveness, however, meme stock mania is losing steam. Not only are hedge funds and other managed investment pools now shoring up their risk exposure to short squeezes, traders are also running out of stocks they can push around.\nThey're also running out of other buyers and bullish arguments.\nSee, for most meme stocks to continue their rallies, new buyers must bring new money to the table to purchase shares from traders that have already scooped up the stock and are now looking to lock in a sizable profit. Enough people were willing to take such a swing early in the year when AMC was trading around $2 per share. Now that it's trading at more than $46 per share, however, would-be buyers are considerably less interested. Underscoring this idea is the fact that shares of Tonix Pharmaceuticals and Clover Health have yet to respond to the same rally driving strategies that -- at least for a while -- buoyed AMC stock. In a similar vein, Skillz shares have also stopped responding to the bullish prompts that drove the stock from around $11 per share in November of last year to February's high in excess of $46. They're now back near $11, unable to keep a rally going.\nThere's something of a litmus test for the entire meme stock movement due this afternoon. Another meme stock company,GameStop(NYSE:GME), is slated to report its fiscal second-quarter numbers after today's closing bell rings. The numbers are important. But even more important is whether or not the trading crowd relaying on the web's popular message boards will be able to convince others to start and sustain a rally from GameStop. If it can, other meme stocks like AMC and Clover will remain at least somewhat in play. If it can't, it may well be a sign that the underlying strategy of individual traders targeting one ticker at a time is no longer effective. This in turn may sour most of them from even trying to do so, continuing the conversion of many of these meme names back to more conventionally priced stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813773882,"gmtCreate":1630259886746,"gmtModify":1676530251846,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HRB\">$H&amp;R Block(HRB)$</a>.","listText":"<a href=\"https://laohu8.com/S/HRB\">$H&amp;R Block(HRB)$</a>.","text":"$H&R Block(HRB)$.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813773882","isVote":1,"tweetType":1,"viewCount":324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813773363,"gmtCreate":1630259850052,"gmtModify":1676530251863,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813773363","repostId":"1129129956","repostType":4,"isVote":1,"tweetType":1,"viewCount":401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836430809,"gmtCreate":1629512793401,"gmtModify":1676530062423,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Aim where?","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Aim where?","text":"$Clover Health Corp(CLOV)$Aim where?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836430809","isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836494103,"gmtCreate":1629512656802,"gmtModify":1676530062384,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Will it sell on news....","listText":"Will it sell on news....","text":"Will it sell on news....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/836494103","repostId":"2161745179","repostType":4,"isVote":1,"tweetType":1,"viewCount":532,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836673146,"gmtCreate":1629484466485,"gmtModify":1676530056465,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Time will tell.... but by then, the answer may have come too late.","listText":"Time will tell.... but by then, the answer may have come too late.","text":"Time will tell.... but by then, the answer may have come too late.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836673146","repostId":"2160710721","repostType":4,"repost":{"id":"2160710721","pubTimestamp":1629473265,"share":"https://www.laohu8.com/m/news/2160710721?lang=&edition=full","pubTime":"2021-08-20 23:27","market":"us","language":"en","title":"Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?","url":"https://stock-news.laohu8.com/highlight/detail?id=2160710721","media":"Zacks","summary":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. ","content":"<p><b>Moderna</b>’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a <a href=\"https://laohu8.com/S/WASH\">Washington</a> <a href=\"https://laohu8.com/S/POST\">Post</a> article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>/<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>’s mRNA-based vaccine, BNT162b.</p>\n<p>Per the same <a href=\"https://laohu8.com/S/WRE\">Washington</a> Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.</p>\n<p>We note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.</p>\n<p>Meanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.</p>\n<p>Shares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/01ae6084260e85bc39bcd6d72d8d9ae0\" tg-width=\"620\" tg-height=\"406\" referrerpolicy=\"no-referrer\"></p>\n<p>Image Source: Zacks Investment Research</p>\n<p>We note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with <b>J&amp;J</b>’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.</p>\n<p>Meanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination.&nbsp;The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).</p>\n<h3><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> Price</h3>\n<p><img src=\"https://static.tigerbbs.com/33512fafdd460236be3b7bc6e113462a\" tg-width=\"545\" tg-height=\"257\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> price | Moderna, Inc. Quote</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-20 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2160710721","content_text":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a Washington Post article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than Pfizer/BioNTech SE’s mRNA-based vaccine, BNT162b.\nPer the same Washington Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the United States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.\nWe note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.\nMeanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.\nShares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.\n\nImage Source: Zacks Investment Research\nWe note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with J&J’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.\nMeanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination. The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).\nModerna, Inc. Price\n\nModerna, Inc. price | Moderna, Inc. Quote","news_type":1},"isVote":1,"tweetType":1,"viewCount":531,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159847038,"gmtCreate":1624958412124,"gmtModify":1703848829475,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159847038","repostId":"2147832042","repostType":4,"isVote":1,"tweetType":1,"viewCount":305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159842799,"gmtCreate":1624958280911,"gmtModify":1703848831740,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Waiting for ORPH","listText":"Waiting for ORPH","text":"Waiting for ORPH","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159842799","repostId":"1104222469","repostType":4,"repost":{"id":"1104222469","pubTimestamp":1624956846,"share":"https://www.laohu8.com/m/news/1104222469?lang=&edition=full","pubTime":"2021-06-29 16:54","market":"us","language":"en","title":"Short Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think Are Ready to Pop","url":"https://stock-news.laohu8.com/highlight/detail?id=1104222469","media":"InvestorPlace","summary":"CLOV tops the list with a 97.88 rating\nShort squeeze stocks have been targeted quite a bit lately as","content":"<p>CLOV tops the list with a 97.88 rating</p>\n<p>Short squeeze stocks have been targeted quite a bit lately as Reddit and retail traders tackle them in an effort to push out hedge funds and ramp up prices.</p>\n<p>As such, it comes as no surprise that some experts are laying out their best bets for short squeeze stocks. That includes Fintel, which released an updated list of stocks with short squeeze potential on Sunday.</p>\n<p>The list from Fintel takes a look at various points of data to determine if a stock has short squeeze potential. It also ranks these stocks on a zero to 100 scale in relation to their peers.</p>\n<p>Let’s take a look at the stocks that&nbsp;Fintel believes are ready for a short squeeze&nbsp;below!</p>\n<p><b>Short Squeeze Stocks to Watch</b></p>\n<ol>\n <li><b>Clover Health Investments</b>(NASDAQ:<b><u>CLOV</u></b>) stock starts the list with a 97.88 rating as shares climb slightly higher in early morning trading today.</li>\n <li><b>Alset Ehome International Inc</b>(NASDAQ:<b><u>AEI</u></b>) shares join the short squeeze list with a 97.38 rating as they dip over 2% lower Monday morning.</li>\n <li><b>Cellect Biotechnology</b>(NASDAQ:<b><u>APOP</u></b>) stock is just below it with a rating of 97.36 and shares seeing a slight drop as of this writing.</li>\n <li><b>Orphazyme A/S</b>(NASDAQ:<b><u>ORPH</u></b>) shares are up next with a 95.96 rating as they fall over 3% this morning.</li>\n <li><b>Digital Brands Group</b>(NASDAQ:<b><u>DBGI</u></b>) stock closes out the short squeeze list from Fintel with a 95.86 rating and the stock falling more than 14%.</li>\n</ol>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Short Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think Are Ready to Pop</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShort Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think Are Ready to Pop\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 16:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/short-squeeze-stocks-clov-aei-and-3-other-stocks-experts-think-are-ready-to-pop/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>CLOV tops the list with a 97.88 rating\nShort squeeze stocks have been targeted quite a bit lately as Reddit and retail traders tackle them in an effort to push out hedge funds and ramp up prices.\nAs ...</p>\n\n<a href=\"https://investorplace.com/2021/06/short-squeeze-stocks-clov-aei-and-3-other-stocks-experts-think-are-ready-to-pop/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DBGI":"Digital Brands Group, Inc.","CLOV":"Clover Health Corp","AEI":"Alset EHome International Inc."},"source_url":"https://investorplace.com/2021/06/short-squeeze-stocks-clov-aei-and-3-other-stocks-experts-think-are-ready-to-pop/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104222469","content_text":"CLOV tops the list with a 97.88 rating\nShort squeeze stocks have been targeted quite a bit lately as Reddit and retail traders tackle them in an effort to push out hedge funds and ramp up prices.\nAs such, it comes as no surprise that some experts are laying out their best bets for short squeeze stocks. That includes Fintel, which released an updated list of stocks with short squeeze potential on Sunday.\nThe list from Fintel takes a look at various points of data to determine if a stock has short squeeze potential. It also ranks these stocks on a zero to 100 scale in relation to their peers.\nLet’s take a look at the stocks that Fintel believes are ready for a short squeeze below!\nShort Squeeze Stocks to Watch\n\nClover Health Investments(NASDAQ:CLOV) stock starts the list with a 97.88 rating as shares climb slightly higher in early morning trading today.\nAlset Ehome International Inc(NASDAQ:AEI) shares join the short squeeze list with a 97.38 rating as they dip over 2% lower Monday morning.\nCellect Biotechnology(NASDAQ:APOP) stock is just below it with a rating of 97.36 and shares seeing a slight drop as of this writing.\nOrphazyme A/S(NASDAQ:ORPH) shares are up next with a 95.96 rating as they fall over 3% this morning.\nDigital Brands Group(NASDAQ:DBGI) stock closes out the short squeeze list from Fintel with a 95.86 rating and the stock falling more than 14%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159849194,"gmtCreate":1624957974818,"gmtModify":1703848819115,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>go go go!","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>go go go!","text":"$Bsquare Corp(BSQR)$go go go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159849194","isVote":1,"tweetType":1,"viewCount":228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126542274,"gmtCreate":1624579973398,"gmtModify":1703840734118,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/126542274","repostId":"1160256327","repostType":4,"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126546812,"gmtCreate":1624579943836,"gmtModify":1703840730039,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>step by step","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>step by step","text":"$Bsquare Corp(BSQR)$step by step","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/126546812","isVote":1,"tweetType":1,"viewCount":207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182345922,"gmtCreate":1623555615766,"gmtModify":1704206058554,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182345922","repostId":"2143178871","repostType":4,"repost":{"id":"2143178871","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623527706,"share":"https://www.laohu8.com/m/news/2143178871?lang=&edition=full","pubTime":"2021-06-13 03:55","market":"sh","language":"en","title":"G7 source praises Biden after 'complete chaos' of Trump","url":"https://stock-news.laohu8.com/highlight/detail?id=2143178871","media":"Reuters","summary":"CARBIS BAY, England, June 12  - U.S. President Joe Biden brought a sharply different tone to the Group of Seven summit from his predecessor Donald Trump by allowing frank and collaborative discussion of global issues without sowing disruptive chaos, a source with knowledge of the discussions told Reuters.\"It used to be complete chaos,\" said the source. \"Before, we were on edge the entire, the whole time just trying to keep the G7 intact - and you don't have to worry about that now.\". \"You can ha","content":"<p>CARBIS BAY, England, June 12 (Reuters) - U.S. President Joe Biden brought a sharply different tone to the Group of Seven summit from his predecessor Donald Trump by allowing frank and collaborative discussion of global issues without sowing disruptive chaos, a source with knowledge of the discussions told Reuters.</p>\n<p>\"It used to be complete chaos,\" said the source. \"Before, we were on edge the entire, the whole time just trying to keep the G7 intact - and you don't have to worry about that now.\"</p>\n<p>\"You can have a frank discussion without having to start it off by saying: 'No. Russia is not going to come back into the G7,'\" the source said.</p>\n<p>The United States is back as a cooperative leader of the free world under Biden, France's Emmanuel Macron said earlier on Saturday, illustrating the relief felt by many key U.S. allies that the tumult of Trump's presidency is over.</p>\n<p>Macron's remark echoed that of British Prime Minister Boris Johnson who hailed Biden on Thursday as \"a big breath of fresh air\".</p>\n<p>Neither Macron nor Johnson drew an explicit parallel between Biden and Trump, though both praised Biden's distinctly cooperative tone and officials said there was relief after Trump at times shocked and bewildered many European allies.</p>\n<p>(Reporting by Guy Faulconbridge; editing by Michael Holden)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>G7 source praises Biden after 'complete chaos' of Trump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nG7 source praises Biden after 'complete chaos' of Trump\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-13 03:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CARBIS BAY, England, June 12 (Reuters) - U.S. President Joe Biden brought a sharply different tone to the Group of Seven summit from his predecessor Donald Trump by allowing frank and collaborative discussion of global issues without sowing disruptive chaos, a source with knowledge of the discussions told Reuters.</p>\n<p>\"It used to be complete chaos,\" said the source. \"Before, we were on edge the entire, the whole time just trying to keep the G7 intact - and you don't have to worry about that now.\"</p>\n<p>\"You can have a frank discussion without having to start it off by saying: 'No. Russia is not going to come back into the G7,'\" the source said.</p>\n<p>The United States is back as a cooperative leader of the free world under Biden, France's Emmanuel Macron said earlier on Saturday, illustrating the relief felt by many key U.S. allies that the tumult of Trump's presidency is over.</p>\n<p>Macron's remark echoed that of British Prime Minister Boris Johnson who hailed Biden on Thursday as \"a big breath of fresh air\".</p>\n<p>Neither Macron nor Johnson drew an explicit parallel between Biden and Trump, though both praised Biden's distinctly cooperative tone and officials said there was relief after Trump at times shocked and bewildered many European allies.</p>\n<p>(Reporting by Guy Faulconbridge; editing by Michael Holden)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143178871","content_text":"CARBIS BAY, England, June 12 (Reuters) - U.S. President Joe Biden brought a sharply different tone to the Group of Seven summit from his predecessor Donald Trump by allowing frank and collaborative discussion of global issues without sowing disruptive chaos, a source with knowledge of the discussions told Reuters.\n\"It used to be complete chaos,\" said the source. \"Before, we were on edge the entire, the whole time just trying to keep the G7 intact - and you don't have to worry about that now.\"\n\"You can have a frank discussion without having to start it off by saying: 'No. Russia is not going to come back into the G7,'\" the source said.\nThe United States is back as a cooperative leader of the free world under Biden, France's Emmanuel Macron said earlier on Saturday, illustrating the relief felt by many key U.S. allies that the tumult of Trump's presidency is over.\nMacron's remark echoed that of British Prime Minister Boris Johnson who hailed Biden on Thursday as \"a big breath of fresh air\".\nNeither Macron nor Johnson drew an explicit parallel between Biden and Trump, though both praised Biden's distinctly cooperative tone and officials said there was relief after Trump at times shocked and bewildered many European allies.\n(Reporting by Guy Faulconbridge; editing by Michael Holden)","news_type":1},"isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114599550,"gmtCreate":1623078376870,"gmtModify":1704195677777,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>first time buying this stock? What is its play like? Any potential target?","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>first time buying this stock? What is its play like? Any potential target?","text":"$Bsquare Corp(BSQR)$first time buying this stock? What is its play like? Any potential target?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/114599550","isVote":1,"tweetType":1,"viewCount":992,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":112897495,"gmtCreate":1622859268917,"gmtModify":1704192561355,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>any idea why sudden volume?","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>any idea why sudden volume?","text":"$Bsquare Corp(BSQR)$any idea why sudden volume?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/112897495","isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119656923,"gmtCreate":1622544455262,"gmtModify":1704185988030,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","listText":"<a href=\"https://laohu8.com/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/119656923","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137445062,"gmtCreate":1622382951456,"gmtModify":1704183686735,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"What's the next meme stock? Missed it this time.","listText":"What's the next meme stock? Missed it this time.","text":"What's the next meme stock? Missed it this time.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/137445062","repostId":"2138929107","repostType":4,"isVote":1,"tweetType":1,"viewCount":317,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134757942,"gmtCreate":1622262357586,"gmtModify":1704182469619,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Nice write up. Keeping the faith with Lucid.","listText":"Nice write up. Keeping the faith with Lucid.","text":"Nice write up. Keeping the faith with Lucid.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/134757942","repostId":"2138102985","repostType":2,"repost":{"id":"2138102985","pubTimestamp":1622131200,"share":"https://www.laohu8.com/m/news/2138102985?lang=&edition=full","pubTime":"2021-05-28 00:00","market":"us","language":"en","title":"Where Will Lucid Motors Be in 5 Years?","url":"https://stock-news.laohu8.com/highlight/detail?id=2138102985","media":"Motley Fool","summary":"Management is enthusiastic about the open road that's ahead.","content":"<html><body><span>\n<p>Remember the '80s? If you do, you probably recall the Cola Wars that dominated Super Bowl commercials and other major TV events. While that battle has waned, a new <a href=\"https://laohu8.com/S/AONE\">one</a> seems to be rising: <a href=\"https://laohu8.com/S/AONE.U\">one</a> involving electric vehicles (EVs).</p>\n<p>While <strong>Tesla</strong> <span>(NASDAQ:TSLA)</span> holds the pole position as the most recognizable luxury EV maker, Lucid Motors -- soon to merge with the SPAC <strong><a href=\"https://laohu8.com/S/CCC.U\">Churchill Capital</a> IV</strong> <span>(NYSE:CCIV)</span> -- is racing ahead in its attempt to challenge the EV king of the road. The upstart manufacturer aired a commercial during the episode of <em>Saturday Night Live</em> that Tesla CEO Elon Musk hosted earlier this month. Besides potential customers, investors have also taken notice of Lucid, so let's look down the road to see what it expects over the next few years. </p>\n<div><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628077%2Fa-woman-waits-for-an-electric-vehicle-to-charge.jpg&amp;w=700&amp;op=resize\" srcset=\"https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/628077/a-woman-waits-for-an-electric-vehicle-to-charge.jpg&amp;w=300&amp;op=resize 300w, https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/628077/a-woman-waits-for-an-electric-vehicle-to-charge.jpg&amp;w=1000&amp;op=resize 1000w, https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/628077/a-woman-waits-for-an-electric-vehicle-to-charge.jpg&amp;w=2000&amp;op=resize 2000w\"/>\n<p>Image source: Getty Images.</p>\n</div>\n<h2>What will roll off the assembly line</h2>\n<p>While no drivers are now seeing any Lucid EVs next to them in traffic, the company expects to have vehicles on the road before 2022 begins. Assembly of the company's first production model, the Lucid Air, will occur at the newly built factory in Arizona in the second half of 2021. Management recently reported that the company has received more than 9,000 reservations for the Lucid Air, and it expects to deliver about 1,000 units of the luxury sedan to customers in North America by the end of the year; deliveries to customers in international markets will commence in 2022.</p>\n<p>Over the next five years, Lucid foresees considerable growth in production, including the introduction of an SUV, Project Gravity, in 2023. With projected Air deliveries rising to 36,000 and Project Gravity deliveries of 12,000, Lucid expects to sell about 48,000 vehicles in 2023.</p>\n<p>By 2026, however, management expects SUV deliveries of about 134,000 to outnumber Air deliveries (about 42,000). Similar to Tesla's approach, Lucid expects to transition from only selling luxury vehicles to also offering more-affordable models, which it expects to introduce in 2025. Growing from 7,000 in 2025 to 75,000 in 2026, sales of the more-affordable vehicles will help the company (presumably) sell 251,000 vehicles in 2026.</p><div></div>\n<h2>Looking for the financials in the crystal ball</h2>\n<p>In seeking to grow vehicle deliveries from less than 1,000 in 2021 to 251,000 five years later, management clearly anticipates considerable success in convincing customers to hop into its driver seats. Investors, however, are likely more interested in where the rubber meets the road: the company's financial projections.</p>\n<div><table border=\"1\">\n<tbody>\n<tr>\n<th scope=\"col\">Metric</th>\n<th scope=\"col\">2022</th>\n<th scope=\"col\">2023</th>\n<th scope=\"col\">2024</th>\n<th scope=\"col\">2025</th>\n<th scope=\"col\">2026</th>\n</tr>\n<tr>\n<td>Revenue</td>\n<td>$2.2 billion</td>\n<td>$5.5 billion</td>\n<td>$9.9 billion</td>\n<td>$14 billion</td>\n<td>$22.8 billion</td>\n</tr>\n<tr>\n<td>Gross profit</td>\n<td>$34 million</td>\n<td>$1.1 billion</td>\n<td>$2.1 billion</td>\n<td>$3.1 billion</td>\n<td>$5.3 billion</td>\n</tr>\n<tr>\n<td>EBITDA (loss)</td>\n<td>($1.1 billion)</td>\n<td>($637 million)</td>\n<td>$592 million</td>\n<td>$1.7 billion</td>\n<td>$2.9 billion</td>\n</tr>\n<tr>\n<td>Free cash flow</td>\n<td>($2.8 billion)</td>\n<td>($3.3 billion)</td>\n<td>($1.5 billion)</td>\n<td>$321 million</td>\n<td>$1.5 billion</td>\n</tr>\n</tbody>\n</table></div>\n<p>Data source: Lucid Motors. </p>\n<p>Based on the belief that it'll sell about 1,000 vehicles this year, Lucid expects to book $97 million on the top line. But with production ramping up next year, management believes revenue will grow considerably and continue to do so for the next five years.</p>\n<p>It expects the company to consistently generate a gross profit, averaging about 22% from 2023 through 2026. To put this in perspective, consider that over the past five years, Tesla has reported an average gross margin of 19.7%. Profitability on an EBITDA basis, on the other hand, isn't expected to occur until 2024. If Lucid meets its revenue and EBITDA forecasts in 2026, it'll generate an EBITDA margin of about 12.7%, comparable to the 13% EBITDA margin that Tesla has reported on a trailing-12-month basis.</p><div></div>\n<p>In terms of cash flow, Lucid expects that it will allocate $1.9 billion for capital expenditures (capex) in 2023 -- the highest amount over the next five years -- presumably to prepare for the production of its SUV that's planned for that year. Over the next several years, capex spending is expected to taper off, ending with the company spending $573 million on capex in 2026. Consequently, Lucid projects generating $1.52 billion in free cash flow in 2026. If we assume (again) that the company meets its revenue forecast, it will translate to a free cash flow margin of 6.7%, the same margin that Tesla has reported over the past 12 months.</p>\n<h2>Let's be clear about Lucid's prospects</h2>\n<p>After taking a look at management's forecasts for the next five years, it's no wonder that investors are excited about Lucid's prospects. With management espousing such an auspicious view of the future, does this mean that EV investors should drive off with an investment and park the stock in their portfolios? Not quite.</p>\n<p>Competition continues to ramp up with upstart EV manufacturers as well as legacy automakers that are shifting gears and committing to more EV-heavy product lineups. In addition, the company will surely face some bumps in the road over the next few years -- challenges that could result in the company failing to meet its growth projections. Additionally, the fact that management has supplied the projected financial figures is critical to note. The investing landscape is littered with companies that have provided ambitious earnings forecasts to drive investor enthusiasm yet who have failed to achieved their own guidance. Therefore, investors should be circumspect about taking managment's projections at face value, considering an investment with caution and weighting the risks accordingly.</p>\n<div></div>\n</span></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Where Will Lucid Motors Be in 5 Years?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhere Will Lucid Motors Be in 5 Years?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-28 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/28/where-will-lucid-be-in-5-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Remember the '80s? If you do, you probably recall the Cola Wars that dominated Super Bowl commercials and other major TV events. While that battle has waned, a new one seems to be rising: one ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/28/where-will-lucid-be-in-5-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/05/28/where-will-lucid-be-in-5-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2138102985","content_text":"Remember the '80s? If you do, you probably recall the Cola Wars that dominated Super Bowl commercials and other major TV events. While that battle has waned, a new one seems to be rising: one involving electric vehicles (EVs).\nWhile Tesla (NASDAQ:TSLA) holds the pole position as the most recognizable luxury EV maker, Lucid Motors -- soon to merge with the SPAC Churchill Capital IV (NYSE:CCIV) -- is racing ahead in its attempt to challenge the EV king of the road. The upstart manufacturer aired a commercial during the episode of Saturday Night Live that Tesla CEO Elon Musk hosted earlier this month. Besides potential customers, investors have also taken notice of Lucid, so let's look down the road to see what it expects over the next few years. \n\nImage source: Getty Images.\n\nWhat will roll off the assembly line\nWhile no drivers are now seeing any Lucid EVs next to them in traffic, the company expects to have vehicles on the road before 2022 begins. Assembly of the company's first production model, the Lucid Air, will occur at the newly built factory in Arizona in the second half of 2021. Management recently reported that the company has received more than 9,000 reservations for the Lucid Air, and it expects to deliver about 1,000 units of the luxury sedan to customers in North America by the end of the year; deliveries to customers in international markets will commence in 2022.\nOver the next five years, Lucid foresees considerable growth in production, including the introduction of an SUV, Project Gravity, in 2023. With projected Air deliveries rising to 36,000 and Project Gravity deliveries of 12,000, Lucid expects to sell about 48,000 vehicles in 2023.\nBy 2026, however, management expects SUV deliveries of about 134,000 to outnumber Air deliveries (about 42,000). Similar to Tesla's approach, Lucid expects to transition from only selling luxury vehicles to also offering more-affordable models, which it expects to introduce in 2025. Growing from 7,000 in 2025 to 75,000 in 2026, sales of the more-affordable vehicles will help the company (presumably) sell 251,000 vehicles in 2026.\nLooking for the financials in the crystal ball\nIn seeking to grow vehicle deliveries from less than 1,000 in 2021 to 251,000 five years later, management clearly anticipates considerable success in convincing customers to hop into its driver seats. Investors, however, are likely more interested in where the rubber meets the road: the company's financial projections.\n\n\n\nMetric\n2022\n2023\n2024\n2025\n2026\n\n\nRevenue\n$2.2 billion\n$5.5 billion\n$9.9 billion\n$14 billion\n$22.8 billion\n\n\nGross profit\n$34 million\n$1.1 billion\n$2.1 billion\n$3.1 billion\n$5.3 billion\n\n\nEBITDA (loss)\n($1.1 billion)\n($637 million)\n$592 million\n$1.7 billion\n$2.9 billion\n\n\nFree cash flow\n($2.8 billion)\n($3.3 billion)\n($1.5 billion)\n$321 million\n$1.5 billion\n\n\n\nData source: Lucid Motors. \nBased on the belief that it'll sell about 1,000 vehicles this year, Lucid expects to book $97 million on the top line. But with production ramping up next year, management believes revenue will grow considerably and continue to do so for the next five years.\nIt expects the company to consistently generate a gross profit, averaging about 22% from 2023 through 2026. To put this in perspective, consider that over the past five years, Tesla has reported an average gross margin of 19.7%. Profitability on an EBITDA basis, on the other hand, isn't expected to occur until 2024. If Lucid meets its revenue and EBITDA forecasts in 2026, it'll generate an EBITDA margin of about 12.7%, comparable to the 13% EBITDA margin that Tesla has reported on a trailing-12-month basis.\nIn terms of cash flow, Lucid expects that it will allocate $1.9 billion for capital expenditures (capex) in 2023 -- the highest amount over the next five years -- presumably to prepare for the production of its SUV that's planned for that year. Over the next several years, capex spending is expected to taper off, ending with the company spending $573 million on capex in 2026. Consequently, Lucid projects generating $1.52 billion in free cash flow in 2026. If we assume (again) that the company meets its revenue forecast, it will translate to a free cash flow margin of 6.7%, the same margin that Tesla has reported over the past 12 months.\nLet's be clear about Lucid's prospects\nAfter taking a look at management's forecasts for the next five years, it's no wonder that investors are excited about Lucid's prospects. With management espousing such an auspicious view of the future, does this mean that EV investors should drive off with an investment and park the stock in their portfolios? Not quite.\nCompetition continues to ramp up with upstart EV manufacturers as well as legacy automakers that are shifting gears and committing to more EV-heavy product lineups. In addition, the company will surely face some bumps in the road over the next few years -- challenges that could result in the company failing to meet its growth projections. Additionally, the fact that management has supplied the projected financial figures is critical to note. The investing landscape is littered with companies that have provided ambitious earnings forecasts to drive investor enthusiasm yet who have failed to achieved their own guidance. Therefore, investors should be circumspect about taking managment's projections at face value, considering an investment with caution and weighting the risks accordingly.","news_type":1},"isVote":1,"tweetType":1,"viewCount":336,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":136510064,"gmtCreate":1622027236558,"gmtModify":1704178077260,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>Will we see another day of push today? Hope to see it break $16 and move further up.","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>Will we see another day of push today? Hope to see it break $16 and move further up.","text":"$Microvision(MVIS)$Will we see another day of push today? Hope to see it break $16 and move further up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/136510064","isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":836494103,"gmtCreate":1629512656802,"gmtModify":1676530062384,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Will it sell on news....","listText":"Will it sell on news....","text":"Will it sell on news....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/836494103","repostId":"2161745179","repostType":4,"isVote":1,"tweetType":1,"viewCount":532,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881542725,"gmtCreate":1631370487667,"gmtModify":1676530536939,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>regret not taking profit when it rose to 11+","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>regret not taking profit when it rose to 11+","text":"$Clover Health Corp(CLOV)$regret not taking profit when it rose to 11+","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/881542725","isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3554171307804467","authorId":"3554171307804467","name":"不轻易买股票","avatar":"https://static.tigerbbs.com/9591045ed55f6fad3186a4cd347989e0","crmLevel":1,"crmLevelSwitch":0},"content":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks.","text":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks.","html":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836673146,"gmtCreate":1629484466485,"gmtModify":1676530056465,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Time will tell.... but by then, the answer may have come too late.","listText":"Time will tell.... but by then, the answer may have come too late.","text":"Time will tell.... but by then, the answer may have come too late.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836673146","repostId":"2160710721","repostType":4,"repost":{"id":"2160710721","pubTimestamp":1629473265,"share":"https://www.laohu8.com/m/news/2160710721?lang=&edition=full","pubTime":"2021-08-20 23:27","market":"us","language":"en","title":"Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?","url":"https://stock-news.laohu8.com/highlight/detail?id=2160710721","media":"Zacks","summary":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. ","content":"<p><b>Moderna</b>’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a <a href=\"https://laohu8.com/S/WASH\">Washington</a> <a href=\"https://laohu8.com/S/POST\">Post</a> article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>/<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>’s mRNA-based vaccine, BNT162b.</p>\n<p>Per the same <a href=\"https://laohu8.com/S/WRE\">Washington</a> Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.</p>\n<p>We note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.</p>\n<p>Meanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.</p>\n<p>Shares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/01ae6084260e85bc39bcd6d72d8d9ae0\" tg-width=\"620\" tg-height=\"406\" referrerpolicy=\"no-referrer\"></p>\n<p>Image Source: Zacks Investment Research</p>\n<p>We note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with <b>J&amp;J</b>’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.</p>\n<p>Meanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination.&nbsp;The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).</p>\n<h3><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> Price</h3>\n<p><img src=\"https://static.tigerbbs.com/33512fafdd460236be3b7bc6e113462a\" tg-width=\"545\" tg-height=\"257\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> price | Moderna, Inc. Quote</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-20 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2160710721","content_text":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a Washington Post article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than Pfizer/BioNTech SE’s mRNA-based vaccine, BNT162b.\nPer the same Washington Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the United States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.\nWe note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.\nMeanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.\nShares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.\n\nImage Source: Zacks Investment Research\nWe note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with J&J’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.\nMeanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination. The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).\nModerna, Inc. Price\n\nModerna, Inc. price | Moderna, Inc. Quote","news_type":1},"isVote":1,"tweetType":1,"viewCount":531,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114599550,"gmtCreate":1623078376870,"gmtModify":1704195677777,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>first time buying this stock? What is its play like? Any potential target?","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>first time buying this stock? What is its play like? Any potential target?","text":"$Bsquare Corp(BSQR)$first time buying this stock? What is its play like? Any potential target?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/114599550","isVote":1,"tweetType":1,"viewCount":992,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":139003284,"gmtCreate":1621570968048,"gmtModify":1704359866140,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>stuck at $18+. What price can it reach?","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>stuck at $18+. What price can it reach?","text":"$Microvision(MVIS)$stuck at $18+. What price can it reach?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/139003284","isVote":1,"tweetType":1,"viewCount":488,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573872079389073","authorId":"3573872079389073","name":"肥仔潜力股","avatar":"https://static.tigerbbs.com/a314146553928a2f422e596fb08cef8f","crmLevel":2,"crmLevelSwitch":0},"content":"stuck at $18... no DCA done?","text":"stuck at $18... no DCA done?","html":"stuck at $18... no DCA done?"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138732309,"gmtCreate":1621961052901,"gmtModify":1704365230006,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a> Any news/reason for the price finally moving?","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a> Any news/reason for the price finally moving?","text":"$Microvision(MVIS)$ Any news/reason for the price finally moving?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/138732309","isVote":1,"tweetType":1,"viewCount":782,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371896437,"gmtCreate":1618925782129,"gmtModify":1704716970102,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>high short volume.&nbsp;can we see MVIS do a GME?","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>high short volume.&nbsp;can we see MVIS do a GME?","text":"$Microvision(MVIS)$high short volume. can we see MVIS do a GME?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371896437","isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346901742,"gmtCreate":1617977897386,"gmtModify":1704705588046,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>The tiger roars!","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>The tiger roars!","text":"$Tiger Brokers(TIGR)$The tiger roars!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346901742","isVote":1,"tweetType":1,"viewCount":139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":352901402,"gmtCreate":1616846559706,"gmtModify":1704799575350,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Waiting for Roblox to do a GME!","listText":"Waiting for Roblox to do a GME!","text":"Waiting for Roblox to do a GME!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/352901402","repostId":"2122444907","repostType":4,"isVote":1,"tweetType":1,"viewCount":99,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":351203768,"gmtCreate":1616595660254,"gmtModify":1704796200331,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"The market is like a story. This has happened for more than a day but news came out later. Feels like a bigger hand is pacing the release of news so that there's some drama/story for the market each day.","listText":"The market is like a story. This has happened for more than a day but news came out later. Feels like a bigger hand is pacing the release of news so that there's some drama/story for the market each day.","text":"The market is like a story. This has happened for more than a day but news came out later. Feels like a bigger hand is pacing the release of news so that there's some drama/story for the market each day.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/351203768","repostId":"1138591041","repostType":4,"repost":{"id":"1138591041","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1616589547,"share":"https://www.laohu8.com/m/news/1138591041?lang=&edition=full","pubTime":"2021-03-24 20:39","market":"fut","language":"en","title":"Oil rises as Suez Canal ship runs aground, demand fears weigh","url":"https://stock-news.laohu8.com/highlight/detail?id=1138591041","media":"Reuters","summary":"LONDON (Reuters) - Oil rose more than 2% on Wednesday after a ship ran aground in the Suez Canal rai","content":"<p>LONDON (Reuters) - Oil rose more than 2% on Wednesday after a ship ran aground in the Suez Canal raising supply concerns, although fears of a slow recovery in demand due to European lockdowns limited gains.</p>\n<p>The giant container ship that has been blocking the Suez Canal for more than a day has been partially refloated and traffic along the fastest shipping route from Europe to Asia is expected to resume soon, port agent GAC said on Wednesday.</p>\n<p>“Price support is coming courtesy of a transport blockage,” said Stephen Brennock of oil broker PVM. “Yet market sentiment will likely struggle to shake off its newfound bearish trend.”</p>\n<p>Brent crude rose $1.48, or 2.4%, to $62.27 a barrel by 1223 GMT, after tumbling 5.9% the previous day. West Texas Intermediate (WTI) climbed $1.32, or 2.3%, to $59.08, having lost 6.2% on Tuesday.</p>\n<p>“The potential disruption to supplies has lifted prices,” said Jeffrey Halley of brokerage OANDA, referring to the Suez incident. “The reprieve seems temporary, though.”</p>\n<p>Oil has recovered from historic lows reached last year as OPEC and its allies made record output cuts. But both benchmarks touched their lowest since February on Tuesday, hit by worries over the pace of economic and demand recovery.</p>\n<p>Italy, France and other European countries have re-imposed movement restrictions. But German Chancellor Angela Merkel said she was reversing a decision for a stricter Easter shutdown. Germany is Europe’s biggest oil consumer.</p>\n<p>Adding to downward pressure, U.S. crude oil inventories jumped by 2.9 million barrels last week, according to trading sources citing data from industry group the American Petroleum Institute.</p>\n<p>The official U.S. supply report is due at 1430 GMT from the Energy Information Administration (EIA). Analysts expect crude stocks to decline by about 300,000 barrels.</p>\n<p>OPEC and its allies, known as OPEC+, meet on April 1 to consider whether to unwind more of their output cuts. Given the latest price drop, the prospect of further easing is “zero at this stage,” Halley of ONADA said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil rises as Suez Canal ship runs aground, demand fears weigh</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil rises as Suez Canal ship runs aground, demand fears weigh\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-24 20:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LONDON (Reuters) - Oil rose more than 2% on Wednesday after a ship ran aground in the Suez Canal raising supply concerns, although fears of a slow recovery in demand due to European lockdowns limited gains.</p>\n<p>The giant container ship that has been blocking the Suez Canal for more than a day has been partially refloated and traffic along the fastest shipping route from Europe to Asia is expected to resume soon, port agent GAC said on Wednesday.</p>\n<p>“Price support is coming courtesy of a transport blockage,” said Stephen Brennock of oil broker PVM. “Yet market sentiment will likely struggle to shake off its newfound bearish trend.”</p>\n<p>Brent crude rose $1.48, or 2.4%, to $62.27 a barrel by 1223 GMT, after tumbling 5.9% the previous day. West Texas Intermediate (WTI) climbed $1.32, or 2.3%, to $59.08, having lost 6.2% on Tuesday.</p>\n<p>“The potential disruption to supplies has lifted prices,” said Jeffrey Halley of brokerage OANDA, referring to the Suez incident. “The reprieve seems temporary, though.”</p>\n<p>Oil has recovered from historic lows reached last year as OPEC and its allies made record output cuts. But both benchmarks touched their lowest since February on Tuesday, hit by worries over the pace of economic and demand recovery.</p>\n<p>Italy, France and other European countries have re-imposed movement restrictions. But German Chancellor Angela Merkel said she was reversing a decision for a stricter Easter shutdown. Germany is Europe’s biggest oil consumer.</p>\n<p>Adding to downward pressure, U.S. crude oil inventories jumped by 2.9 million barrels last week, according to trading sources citing data from industry group the American Petroleum Institute.</p>\n<p>The official U.S. supply report is due at 1430 GMT from the Energy Information Administration (EIA). Analysts expect crude stocks to decline by about 300,000 barrels.</p>\n<p>OPEC and its allies, known as OPEC+, meet on April 1 to consider whether to unwind more of their output cuts. Given the latest price drop, the prospect of further easing is “zero at this stage,” Halley of ONADA said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138591041","content_text":"LONDON (Reuters) - Oil rose more than 2% on Wednesday after a ship ran aground in the Suez Canal raising supply concerns, although fears of a slow recovery in demand due to European lockdowns limited gains.\nThe giant container ship that has been blocking the Suez Canal for more than a day has been partially refloated and traffic along the fastest shipping route from Europe to Asia is expected to resume soon, port agent GAC said on Wednesday.\n“Price support is coming courtesy of a transport blockage,” said Stephen Brennock of oil broker PVM. “Yet market sentiment will likely struggle to shake off its newfound bearish trend.”\nBrent crude rose $1.48, or 2.4%, to $62.27 a barrel by 1223 GMT, after tumbling 5.9% the previous day. West Texas Intermediate (WTI) climbed $1.32, or 2.3%, to $59.08, having lost 6.2% on Tuesday.\n“The potential disruption to supplies has lifted prices,” said Jeffrey Halley of brokerage OANDA, referring to the Suez incident. “The reprieve seems temporary, though.”\nOil has recovered from historic lows reached last year as OPEC and its allies made record output cuts. But both benchmarks touched their lowest since February on Tuesday, hit by worries over the pace of economic and demand recovery.\nItaly, France and other European countries have re-imposed movement restrictions. But German Chancellor Angela Merkel said she was reversing a decision for a stricter Easter shutdown. Germany is Europe’s biggest oil consumer.\nAdding to downward pressure, U.S. crude oil inventories jumped by 2.9 million barrels last week, according to trading sources citing data from industry group the American Petroleum Institute.\nThe official U.S. supply report is due at 1430 GMT from the Energy Information Administration (EIA). Analysts expect crude stocks to decline by about 300,000 barrels.\nOPEC and its allies, known as OPEC+, meet on April 1 to consider whether to unwind more of their output cuts. Given the latest price drop, the prospect of further easing is “zero at this stage,” Halley of ONADA said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":328403845,"gmtCreate":1615545852887,"gmtModify":1704784374304,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[OK]&nbsp;","listText":"[OK]&nbsp;","text":"[OK]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328403845","repostId":"1199156489","repostType":4,"repost":{"id":"1199156489","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615452861,"share":"https://www.laohu8.com/m/news/1199156489?lang=&edition=full","pubTime":"2021-03-11 16:54","market":"us","language":"en","title":"US Daylight Saving Time","url":"https://stock-news.laohu8.com/highlight/detail?id=1199156489","media":"Tiger Newspress","summary":"From 02:00 U.S. East time March 14(this Sunday),the North America region entered daylight saving tim","content":"<p>From&nbsp;02:00&nbsp;U.S.&nbsp;East&nbsp;time&nbsp;March&nbsp;14(this&nbsp;Sunday),the&nbsp;North America&nbsp;region&nbsp;entered&nbsp;daylight saving&nbsp;time,until&nbsp;02:00&nbsp;U.S.&nbsp;East&nbsp;time&nbsp;ends&nbsp;on&nbsp;November&nbsp;7,2021.</p><p>So,starting&nbsp;on&nbsp;Monday,March&nbsp;14,the&nbsp;U.S.&nbsp;market&nbsp;will&nbsp;open&nbsp;and&nbsp;close&nbsp;one&nbsp;hour&nbsp;ahead&nbsp;of&nbsp;schedule&nbsp;during&nbsp;north&nbsp;american&nbsp;daylight saving time,i.e.,U.S.&nbsp;trading&nbsp;time&nbsp;will&nbsp;be&nbsp;changed&nbsp;to&nbsp;21:30&nbsp;beijing&nbsp;time&nbsp;to&nbsp;04:00&nbsp;a.m.the&nbsp;next&nbsp;day,pre-trade&nbsp;time&nbsp;will&nbsp;be&nbsp;16:00&nbsp;to&nbsp;21:30,after-trade&nbsp;time&nbsp;will&nbsp;be&nbsp;04:00&nbsp;to&nbsp;8:00.</p><p><b>What is daylight saving time?</b></p><p>The DST is the practice of moving clocks forward by one hour during summer months so that daylight lasts longer into evening. Most of North America and Europe follows the custom, while the majority of countries elsewhere do not.</p><p>Hawaii, American Samoa, Guam, Puerto Rico, the US Virgin Islands and most of Arizona don’t observe daylight saving time. It’s incumbent to stick with the status quo.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US Daylight Saving Time</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS Daylight Saving Time\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-11 16:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>From&nbsp;02:00&nbsp;U.S.&nbsp;East&nbsp;time&nbsp;March&nbsp;14(this&nbsp;Sunday),the&nbsp;North America&nbsp;region&nbsp;entered&nbsp;daylight saving&nbsp;time,until&nbsp;02:00&nbsp;U.S.&nbsp;East&nbsp;time&nbsp;ends&nbsp;on&nbsp;November&nbsp;7,2021.</p><p>So,starting&nbsp;on&nbsp;Monday,March&nbsp;14,the&nbsp;U.S.&nbsp;market&nbsp;will&nbsp;open&nbsp;and&nbsp;close&nbsp;one&nbsp;hour&nbsp;ahead&nbsp;of&nbsp;schedule&nbsp;during&nbsp;north&nbsp;american&nbsp;daylight saving time,i.e.,U.S.&nbsp;trading&nbsp;time&nbsp;will&nbsp;be&nbsp;changed&nbsp;to&nbsp;21:30&nbsp;beijing&nbsp;time&nbsp;to&nbsp;04:00&nbsp;a.m.the&nbsp;next&nbsp;day,pre-trade&nbsp;time&nbsp;will&nbsp;be&nbsp;16:00&nbsp;to&nbsp;21:30,after-trade&nbsp;time&nbsp;will&nbsp;be&nbsp;04:00&nbsp;to&nbsp;8:00.</p><p><b>What is daylight saving time?</b></p><p>The DST is the practice of moving clocks forward by one hour during summer months so that daylight lasts longer into evening. Most of North America and Europe follows the custom, while the majority of countries elsewhere do not.</p><p>Hawaii, American Samoa, Guam, Puerto Rico, the US Virgin Islands and most of Arizona don’t observe daylight saving time. It’s incumbent to stick with the status quo.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199156489","content_text":"From 02:00 U.S. East time March 14(this Sunday),the North America region entered daylight saving time,until 02:00 U.S. East time ends on November 7,2021.So,starting on Monday,March 14,the U.S. market will open and close one hour ahead of schedule during north american daylight saving time,i.e.,U.S. trading time will be changed to 21:30 beijing time to 04:00 a.m.the next day,pre-trade time will be 16:00 to 21:30,after-trade time will be 04:00 to 8:00.What is daylight saving time?The DST is the practice of moving clocks forward by one hour during summer months so that daylight lasts longer into evening. Most of North America and Europe follows the custom, while the majority of countries elsewhere do not.Hawaii, American Samoa, Guam, Puerto Rico, the US Virgin Islands and most of Arizona don’t observe daylight saving time. It’s incumbent to stick with the status quo.","news_type":1},"isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813773363,"gmtCreate":1630259850052,"gmtModify":1676530251863,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813773363","repostId":"1129129956","repostType":4,"repost":{"id":"1129129956","pubTimestamp":1630201285,"share":"https://www.laohu8.com/m/news/1129129956?lang=&edition=full","pubTime":"2021-08-29 09:41","market":"us","language":"en","title":"This Unloved Tech Stock Could Make You Rich One Day","url":"https://stock-news.laohu8.com/highlight/detail?id=1129129956","media":"Motley Fool","summary":"The iBuying business is a race to grow larger, and Opendoor is winning.The company is growing at a rate that is two years ahead of what management projected just a year earlier.The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.Real estate iBuying company Opendoor Technologieshas been executing at a high level in the three quarters since coming public via a special purpose acquisition company  merger. In a race to disrupt residential ","content":"<p>Key Points</p>\n<ul>\n <li>The iBuying business is a race to grow larger, and Opendoor is winning.</li>\n <li>The company is growing at a rate that is two years ahead of what management projected just a year earlier.</li>\n <li>The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.</li>\n</ul>\n<p></p>\n<p>Real estate iBuying company&nbsp;<b>Opendoor Technologies</b>(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.</p>\n<p>Despite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.</p>\n<h3>1. Opendoor is winning the iBuying battle</h3>\n<p>The traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.</p>\n<p>Opendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.</p>\n<p>After seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including&nbsp;<b>Zillow Group</b>&nbsp;and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.</p>\n<p>According to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.</p>\n<h3>2. Revenue growth is ahead of schedule</h3>\n<p>When companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.</p>\n<p>Fast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"</p>\n<p>In other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.</p>\n<h3>3. SPACs are out of favor with the market... opportunity?</h3>\n<p>Investors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.</p>\n<p>Investors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.</p>\n<p>But if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.</p>\n<p>Competitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.</p>\n<h3>Here's the bottom line</h3>\n<p>Real estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"<b>Amazon</b>\" of home buying, but what seems certain is that the company is&nbsp;poised to be a big player&nbsp;in real estate's future if it keeps performing like this.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Unloved Tech Stock Could Make You Rich One Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Unloved Tech Stock Could Make You Rich One Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-29 09:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OPEN":"Opendoor Technologies Inc"},"source_url":"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129129956","content_text":"Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.\n\n\nReal estate iBuying company Opendoor Technologies(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.\nDespite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.\n1. Opendoor is winning the iBuying battle\nThe traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.\nOpendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.\nAfter seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including Zillow Group and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.\nAccording to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.\n2. Revenue growth is ahead of schedule\nWhen companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.\nFast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"\nIn other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.\n3. SPACs are out of favor with the market... opportunity?\nInvestors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.\nInvestors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.\nBut if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.\nCompetitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.\nHere's the bottom line\nReal estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"Amazon\" of home buying, but what seems certain is that the company is poised to be a big player in real estate's future if it keeps performing like this.","news_type":1},"isVote":1,"tweetType":1,"viewCount":401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":379334337,"gmtCreate":1618671699629,"gmtModify":1704713974855,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CCIV\">$Churchill Capital Corp IV(CCIV)$</a>anybody knows&nbsp;what are the potential catalysts for this stock to rebound?","listText":"<a href=\"https://laohu8.com/S/CCIV\">$Churchill Capital Corp IV(CCIV)$</a>anybody knows&nbsp;what are the potential catalysts for this stock to rebound?","text":"$Churchill Capital Corp IV(CCIV)$anybody knows what are the potential catalysts for this stock to rebound?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/379334337","isVote":1,"tweetType":1,"viewCount":636,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578631106874889","authorId":"3578631106874889","name":"Starship89","avatar":"https://static.tigerbbs.com/32ff2a09eb9746949c2dd2367dedee47","crmLevel":2,"crmLevelSwitch":1},"content":"Most probably till we start seeing test drive by public and review. Till now we’ve yet to see any lucid EV on the road other than CEO is driving. It is obvious why it falls so hard.","text":"Most probably till we start seeing test drive by public and review. Till now we’ve yet to see any lucid EV on the road other than CEO is driving. It is obvious why it falls so hard.","html":"Most probably till we start seeing test drive by public and review. Till now we’ve yet to see any lucid EV on the road other than CEO is driving. It is obvious why it falls so hard."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320159889,"gmtCreate":1615048808541,"gmtModify":1704778389346,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/U09.SI\">$AVARGA LIMITED(U09.SI)$</a>Waiting for PL to show his magic power. Be patient.","listText":"<a href=\"https://laohu8.com/S/U09.SI\">$AVARGA LIMITED(U09.SI)$</a>Waiting for PL to show his magic power. Be patient.","text":"$AVARGA LIMITED(U09.SI)$Waiting for PL to show his magic power. Be patient.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320159889","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159847038,"gmtCreate":1624958412124,"gmtModify":1703848829475,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159847038","repostId":"2147832042","repostType":4,"isVote":1,"tweetType":1,"viewCount":305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126542274,"gmtCreate":1624579973398,"gmtModify":1703840734118,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/126542274","repostId":"1160256327","repostType":4,"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119656923,"gmtCreate":1622544455262,"gmtModify":1704185988030,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","listText":"<a href=\"https://laohu8.com/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/119656923","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":107468378,"gmtCreate":1620530058994,"gmtModify":1704344660719,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>when can I see it green in my portfolio again...","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>when can I see it green in my portfolio again...","text":"$Microvision(MVIS)$when can I see it green in my portfolio again...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/107468378","isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}